1.The clinical study on treatment with bortezomib for multiple myeloma.
Chen CHEN ; Chuan-li ZHAO ; Ming HOU
Chinese Journal of Hematology 2011;32(4):265-267
Adult
;
Aged
;
Antineoplastic Combined Chemotherapy Protocols
;
administration & dosage
;
therapeutic use
;
Boronic Acids
;
administration & dosage
;
therapeutic use
;
Bortezomib
;
Female
;
Humans
;
Male
;
Middle Aged
;
Multiple Myeloma
;
drug therapy
;
Pyrazines
;
administration & dosage
;
therapeutic use
2.Research progress of polyethylene inserts wear measurement and evaluation in total knee arthroplasty.
Feng ZHAO ; Chuan WANG ; Yubo FAN
Chinese Journal of Medical Instrumentation 2015;39(1):33-36
Wear of polyethylene (PE) tibial inserts is a significant cause of implant failure of total knee arthroplasty (TKA). PE inserts wear measurement and evaluation is the key in TKA researches. There are many methods to measure insert wear. Qualitative methods such as observation are used to determine the wear and its type. Quantitative methods such as gravimetric analysis, coordinate measuring machines (CMM) and micro-computed tomography (micro-CT) are used to measure the mass, volume and geometry of wear. In this paper, the principle, characteristics and research progress of main insert wear evaluation method were introduced and the problems and disadvantages were analyzed.
Arthroplasty, Replacement, Knee
;
Humans
;
Knee Prosthesis
;
Polyethylene
;
Prosthesis Design
;
Prosthesis Failure
;
Tibia
;
Tomography, X-Ray Computed
;
X-Ray Microtomography
5.Effect of yanshen no. 1 on the residual renal function in patients undergoing hematodialysis.
Jin-chuan TAN ; Yu-yong ZHAO ; Gang WANG
Chinese Journal of Integrated Traditional and Western Medicine 2003;23(10):781-782
Adolescent
;
Adult
;
Aged
;
Blood Urea Nitrogen
;
Creatinine
;
blood
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Humans
;
Kidney
;
physiopathology
;
Kidney Function Tests
;
Male
;
Middle Aged
;
Phytotherapy
;
Renal Dialysis
;
Uremia
;
physiopathology
;
therapy
6.Modified pinning combined with external tension band for the treatment of Gartland type III humeral supracondylar fractures in children.
Chuan ZHANG ; Zuo-Jun ZHANG ; Ming ZHAO ; Zhong-Xiao CHANG
China Journal of Orthopaedics and Traumatology 2012;25(8):690-693
OBJECTIVETo explore therapeutic effects of Modified pinning combined with external tension band for the treatment of Gartland type III humeral supracondylar fractures in children.
METHODSFrom February 2009 to November 2010, 79 children with Gartland type III humeral supracondylar fractures were treated by modified pinning (pinning cross internal and external condyle assisted with lateral condyle) combined with external tension band (crossing needle end and hooking around) through lateral approach of elbow. There were 47 males and 32 females, with an average age of 8.7 years (ranging from 2.5 to 14 years). The time from injury to operation was 2 h to 8 d. The elbow joint function and Carrying angle were observed before and after treatment. The Flynn criteria were used to evaluate therapeutic effects.
RESULTSSixty-one patients were followed up (18 patients' data were lost) for 6-30 months (mean 13.5 months). According to Flynn criteria, 53 patients got excellent result, 7 good and 1 fair.
CONCLUSIONTreatment of child Gartland type III humeral supracondylar fractures with modified pinning combined with external tension band through lateral approach of elbow is believed to be an ideal method, which has advantages of reliable fixation, rapid recovery and less complications.
Adolescent ; Bone Nails ; Child ; Child, Preschool ; Female ; Fracture Fixation ; instrumentation ; methods ; Humans ; Humeral Fractures ; diagnostic imaging ; surgery ; Male ; Mechanical Phenomena ; Radiography ; Treatment Outcome
7.Effect of F89 on body v levels of Gaoyou duck.
Yu-chuan ZHOU ; Yin-xue XU ; Ru qian ZHAO
Chinese Journal of Applied Physiology 2002;18(4):316-328
Animals
;
Benzodiazepines
;
pharmacology
;
Ducks
;
physiology
;
Growth Hormone
;
blood
;
Insulin-Like Growth Factor I
;
metabolism
;
Serum
;
metabolism
;
Weight Gain
;
drug effects
9.Effect of plumbagin on invasion and apoptosis of human hepatocellular carcinoma cell line HepG2
Jinling XIE ; Chuan ZHAO ; Junxuan LI ; Yanfei WEI
Chinese Pharmacological Bulletin 2016;32(5):687-691
Aim To investigate the effect of plumbagin on invasion and apoptosis of human hepatocellular car-cinoma ( HepG2 ) . Methods HepG2 cells were cul-tured in vitro with different concentrations of plumba-gin, then cell proliferation was observed by MTT as-say; cell invasion was observed by transwell invasion assay; cell apoptosis was detected by flow cytometry, and the protein expression of Bax, Bcl-2 was detected by immunocytochemistry. Results MTT results showed that plumbagin could significantly inhibit cell proliferation compared with the control group, and in a dose-dependent manner ( P <0. 05 ) . Transwell inva-sion assay showed that cell invasion was significantly decreased with increasing concentrations of plumbagin ( P < 0. 01 ) . Flow cytometry showed that apoptosis rate was significantly higher in 4 , 8 μmol · L-1 group of plumbagin compared with that of the control group ( P<0. 01 ) . Immunocytochemistry showed that, with the increasing concentration of plumbagin, Bax protein expression increased, Bcl-2 protein expression was de-creased, both in a dose-dependent manner ( P <0. 01 ) . Conclusion Plumbagin can inhibit HepG2 cell proliferation and accelerate apoptosis of HepG2 cells, but also has the ability to inhibit HepG2 cell in-vasion.
( P < 0. 01 ) . Flow cytometry showed that apoptosis rate was significantly higher in 4 , 8 μmol · L-1 group of plumbagin compared with that of the control group ( P<0. 01 ) . Immunocytochemistry showed that, with the increasing concentration of plumbagin, Bax protein expression increased, Bcl-2 protein expression was de-creased, both in a dose-dependent manner ( P <0. 01 ) . Conclusion Plumbagin can inhibit HepG2 cell proliferation and accelerate apoptosis of HepG2 cells, but also has the ability to inhibit HepG2 cell in-vasion.
10.Ventral bladder mucosa onlay graft urethroplasty for the treatment of panurethral stricture
Chuan HAO ; Zhenli ZHAO ; Chengyong LI ; Yuzhuo LI ; Yong GU
Chinese Journal of Urology 2016;37(3):195-198
Objective To investigate the efficacy of ventral bladder mucosa onlay graft urethroplasty for the management of panurethral stricture.Methods From August of 2005 to July of 2013,11 cases of panurethral stricture were treated by ventral bladder mucosa onlay graft urethroplasty.The median age of the patients was 53 years (22-72 year),The median stricture length was 15 cm (12-18 cm).The patient was placed in the lithotomy position,Penile urethra was exposed by circumcoronal incision and degloving of skin,Bulbar urethra was exposed by inverted Y-shaped perineal incision.The strictured urethral segment was then opened ventrally in the midline up to at least 1 cm proximally into the healthy urethra.An appropriate size bladder mucosa graft was harvested,and was quilted to the splited urethra edge,the graft width was 1.5-2.0 cm.Two F10 fenestrated silicone catheters were left as urethral stents,a suprapupic cystostomy tube was left.The urethral stent was removed 4 weeks postoperatively.Follow-up was performed every 3 months for the first year,and annually thereafter.Success was defined as normal voiding with a maximum flow rates ≥ 15 ml/s,and the patients required no further instrumentation,including dilation or urethrotomy.Results The mean follow-up was 18 months (range,9-36 months),the overall success rate was 10/11.One patient developed urethral meatus stenosis 3 months postoperatively,and was managed by meatal dilatation.Conclusion Ventral bladder mucosa onlay graft urethroplasty can be used for the management of panurethral stricture,Bladder mucosa is an alternative substitution for complex urethral reconstruction.